Understanding the Activity of Antibiotics in Cerebrospinal Fluid in vitro
Author(s) -
Peter Matzneller,
Angela Burian,
Markus Zeitlinger,
Robert Sauermann
Publication year - 2016
Publication title -
pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.51
H-Index - 59
eISSN - 1423-0313
pISSN - 0031-7012
DOI - 10.1159/000444263
Subject(s) - antibiotics , in vivo , medicine , ventriculitis , cerebrospinal fluid , vancomycin , cefotaxime , meningitis , antimicrobial , pharmacology , ciprofloxacin , in vitro , gentamicin , biology , microbiology and biotechnology , bacteria , surgery , biochemistry , genetics , staphylococcus aureus
In vitro studies suggest that antimicrobial activity of antibiotics meant to treat central nervous system infections such as meningitis or ventriculitis may be altered by cerebrospinal fluid (CSF). This could explain the reason behind the often observed discrepancies between the activity of antibiotics determined in artificial growth media in vitro, and their sometimes reduced clinical efficacy in CSF in vivo. If conducted in CSF, in vitro microbiological investigations might predict the ability of antibiotic drugs to treat CSF infections better than experiments in artificial growth media. In addition, they are less expensive, critical and time consuming than animal studies, and might potentially be appreciated in drug development as a rapid and cost-effective means to gain valuable information on drugs meant to treat infections residing in CSF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom